MarketPeel
Insider Trading Intelligence
Pricing
…
KF

Kathleen Ford

KURA
CHIEF OPERATING OFFICER · KURA ONCOLOGY, INC. · CIK 0001785406
FILING MIX · LIFETIME43%/57%
BUYS
16
SELLS
21
TOTAL VALUE
$2.11M
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
153,560
AVG SELL PX
$24.18
TRADE KIND
SHOWING 37 / 37
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
14 backtested trades · 8 horizons · 10 pending
Forward-return performance of every backtestable P/S trade by Kathleen Ford, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d14+64.29%-1.98%-0.28%-1.70%-1.55%—
14d14+50.00%-3.35%+0.57%-3.92%-2.82%—
30d14+57.14%-1.69%+1.51%-3.20%-1.74%—
60d14+64.29%-0.91%+2.90%-3.81%-5.46%—
90d14+57.14%-5.03%+4.80%-9.83%-15.45%—
180d14(1 pending)+69.23%-14.74%+11.52%-26.26%-25.95%—
1y14(3 pending)+72.73%-26.89%+24.23%-51.12%-62.39%—
2y14(6 pending)+100.00%-56.93%+20.84%-77.77%-76.48%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
KURA · 153,560 shares · as of May 19, 2026
060,938121,875182,813243,750202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 16 buys / 21 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
KURA
KURA ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
2,257$9.08$20.5K153,560May 19, 2026May 20, 2026 ↗View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Operating Officer
1,813$8.46$15.3K153,560Jan 27, 2026Jan 27, 2026 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
50,000——155,373Jan 2, 2026Jan 6, 2026 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
100,000——100,000Jan 2, 2026Jan 6, 2026 ↗View →
KURA
KURA ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
6,902$11.18$77.1K105,373Nov 14, 2025Nov 14, 2025 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
48,900——112,275Nov 13, 2025Nov 14, 2025 ↗View →
KURA
KURA ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
6,892$8.94$61.6K63,375Sep 29, 2025Sep 29, 2025 ↗View →
KURA
KURA ONCOLOGY, INC.
SALEGRANT
Stock grant
48,900——70,267Sep 27, 2025Sep 29, 2025 ↗View →
KURA
KURA ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
1,558$6.28$9.8K21,367May 19, 2025May 19, 2025 ↗View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Operating Officer
1,817$7.87$14.3K21,367Jan 28, 2025Jan 28, 2025 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
185,000——185,000Jan 2, 2025Jan 6, 2025 ↗View →
KURA
KURA ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
526$16.03$8.4K23,184Nov 18, 2024Nov 19, 2024 ↗View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Operating Officer
1,496$17.80$26.6K21,602Jan 29, 2024Jan 31, 2024 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
185,000——185,000Jan 2, 2024Jan 4, 2024 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
185,000——185,000Feb 16, 2023Feb 21, 2023 ↗View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Operating Officer
1,821$13.89$25.3K21,214Jan 27, 2023Jan 31, 2023 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
171,000——171,000Jan 26, 2022Jan 28, 2022 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
21,900——23,035Jan 26, 2022Jan 28, 2022 ↗View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Operating Officer
6,250——215,625Mar 15, 2021Mar 17, 2021 ↗View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Operating Officer
6,250$29.43$184.0K0Mar 15, 2021Mar 17, 2021 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASE
Chief Operating Officer
6,250$19.43$121.4K6,250Mar 15, 2021Mar 17, 2021 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
140,000——140,000Jan 26, 2021Jan 28, 2021 ↗View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Operating Officer
9,375——221,875Dec 15, 2020Dec 16, 2020 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASE
Chief Operating Officer
6,250$19.43$121.4K6,250Dec 15, 2020Dec 16, 2020 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASE
Chief Operating Officer
3,125$19.43$60.7K3,125Dec 15, 2020Dec 16, 2020 ↗View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Operating Officer
6,250$40.60$253.8K0Dec 15, 2020Dec 16, 2020 ↗View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Operating Officer
3,125$40.60$126.9K0Dec 15, 2020Dec 16, 2020 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASE
Chief Operating Officer
6,250$19.43$121.4K6,250Nov 10, 2020Nov 12, 2020 ↗View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Operating Officer
6,250$39.43$246.4K0Nov 10, 2020Nov 12, 2020 ↗View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Operating Officer
6,250——231,250Nov 10, 2020Nov 12, 2020 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASE
Chief Operating Officer
6,250$19.43$121.4K6,250Sep 15, 2020Sep 15, 2020 ↗View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Operating Officer
6,250$29.43$183.9K0Sep 15, 2020Sep 15, 2020 ↗View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Operating Officer
6,250——237,500Sep 15, 2020Sep 15, 2020 ↗View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Operating Officer
6,250$29.43$183.9K0Sep 14, 2020Sep 15, 2020 ↗View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Operating Officer
6,250——243,750Sep 14, 2020Sep 15, 2020 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASE
Chief Operating Officer
6,250$19.43$121.4K6,250Sep 14, 2020Sep 15, 2020 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
45,393——45,393Jan 30, 2020Feb 3, 2020 ↗View →
Other insiders · KURA
Loading peer insiders…
About this filer
CIK 0001785406
ROLE
Chief Operating Officer
PRIMARY
KURA
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001785406DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback